Fine Mark National Bank & Trust Steris PLC Transaction History

Fine Mark National Bank & Trust

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$197.44 - $227.52 $8,292 - $9,555	-42 Reduced 3.98%	1,012 $222,000
Q1 2023 May 08, 2023	SELL	$176.39 - $220.86 $66,499 - $83,264	-377 Reduced 26.35%	1,054 $201,000
Q4 2022 Feb 09, 2023	SELL	$160.98 - $199.08 $1,770 - $2,189	-11 Reduced 0.76%	1,431 $264,000
Q3 2022 Nov 14, 2022	SELL	$160.72 - $225.65 $33,751 - $47,386	-210 Reduced 12.71%	1,442 $240,000
Q2 2022 Aug 09, 2022	BUY	$192.78 - $252.92 $32,387 - $42,490	168 Added 11.32%	1,652 $341,000
Q1 2022 May 16, 2022	SELL	$215.16 - $247.18 $19,149 - $21,999	-89 Reduced 5.66%	1,484 $359,000
Q3 2021 Nov 12, 2021	SELL	$204.28 - $225.82 $1,225 - $1,354	-6 Reduced 0.38%	1,573 $321,000
Q2 2021 Aug 13, 2021	BUY	$188.43 - $216.47 $297,530 - $341,806	1,579 New	1,579 $326,000

812

94.5M

72.6K

12K

Ticker STE
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 100,015,000
Market Cap $22B
Description
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking prod...

Get notified when there are updates to the investment portfolio of Fine Mark National Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Fine Mark National Bank & Trust with notifications on news.